Abbott Laboratories (NYSE: ABT) is scheduled to announce Q2 earnings results on Thursday, July 17th, before market open.

Healthcare product and device company Abbott Laboratories (NYSE:ABT) will be announcing earnings results this Thursday ...

Abbott Laboratories closed 6.52% below its 52-week high of $141.23, which the company reached on March 4th.

Abbott Laboratories ABT is preparing to release its quarterly earnings on Thursday, 2025-07-17. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect ...

Barclays analyst Matt Miksic maintained an Overweight rating and increased the price target from $158 to $159 on April 17, ...

Abbott Laboratories (NYSE: ABT) is one of the stocks that Jim Cramer shared insights on. While discussing the stock, Cramer ...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good ...

Abbott Laboratories’ Debt totaled $15 Bil at the end of the latest quarter, while its market capitalization stands at $233 ...

Abbott Laboratories (NYSE:ABT) is one of the high profit margin stocks to buy now. On June 19, Beta Bionics Inc.

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

With a market cap of $233.8 billion, Abbott Laboratories (ABT) is a global healthcare company that discovers, develops, manufactures, and sells a diverse range of healthcare products across ...